$EMC & $ALEF stand to come out ahead on $TLRY’s Natura deal. But can they keep their supply?
Breaking down the fundamentals behind the hype in the $GGB offer for $APHA.
$TLRY’s deal for Natura Naturals is putting on a clinic in risk pricing, just in time for our series on de-risking in the cannabis space.
$ACB’s made a $175M all-stock bid for private Whistler Medical after unloading some $TGOD. $CRON may have something to say about this before it’s over.
All eyes were on $APHA Friday, as the best soap opera in the pot world arrived at the much-anticipated culmination of its latest high-drama plot arc, and payed it off in epic fashion.
$APHA is still at the top of the product mix, with $WEED close behind. Some big moves this month, including the rise of $TLRY retail and a new launch from $OGI.
In a Boxing Day video message to his subscribers, Namaste Technologies $N CEO Sean Dollinger told the Namaste faithful that he was no longer going to be doing Namaste 420, the weekly web address and talk show that they tuned in to religiously, effectively cancelling the best show in small cap.
This $GGB bid for $APHA scans like a stunt. But if they stick the landing, and everyone’s still watching, why stop the show?
Despite a full-on collapse in equity markets on both sides of the border, hope springs eternal in the still-young marijuana business.
Namaste’s superpower is being able to get across to the retail crowd better than any of their peers. Tragically, they don’t know how to use it.